Bristol Letters Warn Of Hydroxyurea-Related Ulcers And Gangrene
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol is cautioning providers to take precautions when handling its Hydrea cancer treatment and Droxia sickle cell anemia therapy.